###begin article-title 0
Peroxisome Proliferator-Activated Receptor- (PPAR-) Agonists Attenuate the Profibrotic Response Induced by TGF-1 in Renal Interstitial Fibroblasts
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background.</italic>
###xml 372 381 372 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> Methods.</italic>
###xml 732 740 732 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results.</italic>
###xml 1363 1374 1363 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion.</italic>
###xml 385 388 <span type="species:ncbi:10116">rat</span>
Background. Studies have shown that peroxisome proliferator-activated receptor- (PPAR-) agonists could ameliorate renal fibrotic lesions in both diabetic nephropathy and nondiabetic chronic kidney diseases. In order to elucidate the antifibrotic mechanism of PPAR- agonists, we investigated the effects of PPAR- activation on TGF-1-induced renal interstitial fibroblasts.  Methods. In rat renal interstitial fibroblasts (NRK/49F), the mRNA expression of TGF-1-induced -smooth muscle actin (-SMA), connective tissue growth factor (CTGF), fibronectin (FN) and collagen type III (Col III) were observed by reverse transcriptase-polymerase chain reaction (RT-PCR). The protein expressions of FN and Smads were observed by Western blot. Results. In NRK/49F, TGF-1 enhanced CTGF, FN and Col III mRNA expression in a dose- and time-dependent manner. -SMA, CTGF, FN and Col III mRNA and FN protein expression in 15-deoxy--prostaglandin J2 (15d-PGJ2)-troglitazone- and ciglitazone-pretreated groups, respectively, were significantly decreased compared with the TGF-1-stimulated group. TGF-1 (5 ng/mL) enhanced p-Smad2/3 protein expression in a time-dependent manner. Compared with the TGF-1-stimulated group, p-Smad2/3 protein induced by TGF-1 in PPAR- agonists-pretreated groups significantly decreased with no statistical difference amongst the three pretreated groups. Conclusion. PPAR- agonists could inhibit TGF-1-induced renal fibroblast activation, CTGF expression and ECM synthesis through abrogating the TGF-1/Smads signaling pathway.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 485 489 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 495 499 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 703 707 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 752 757 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 764 769 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 902 903 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 904 905 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 913 918 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 961 966 936 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12,14</sup>
###xml 982 983 957 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 992 993 967 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1044 1049 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1122 1123 1093 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1264 1269 1235 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1369 1370 1336 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1372 1373 1339 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1535 1540 1502 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1658 1659 1621 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1667 1672 1630 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1794 1798 1753 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1880 1881 1836 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1883 1884 1839 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1892 1897 1848 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 2019 2023 1971 1972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 2036 2038 1985 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 2076 2080 2025 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 2191 2193 2137 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 2194 2196 2140 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 2233 2238 2179 2180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 2321 2326 2263 2264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 2345 2349 2283 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 2473 2478 2408 2409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1464 1467 <span type="species:ncbi:10116">rat</span>
###xml 1718 1723 <span type="species:ncbi:9606">human</span>
###xml 2116 2121 <span type="species:ncbi:10090">mouse</span>
Tubulointerstitial fibrosis (TIF) is the final manifestation of end stage renal disease (ESRD) [1] and renal injury is correlated to the degree of renal interstitial fibrosis. One of the major pathological characteristics of TIF is the activated tubulointerstitial fibroblasts transdifferentiating into myofibroblasts. Furthermore, extracellular matrix (ECM) secreted by fibroblasts deposits in the tubular interstitium and results in interstitial fibrosis. Transforming growth factor-beta (TGF-beta) is known to be one of the major mediators that lead to fibrosis. Connective tissue growth factor (CTGF) has been receiving more and more attention for being one of the major downstream mediators of TGF-beta. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) is a member of the ligand-activated nuclear transcriptional superfamily and is expressed in several tissues which includes kidney [2-5]. PPAR-gamma is activated by its ligand, 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2), or activators (synthetic thiazolidinedione PPAR-gamma agonists) and then participates in the regulation of cellular function [2]. Apart from maintaining glucose homeostasis, it also plays an important role in inflammation and cell cycles. Studies have shown that PPAR-gamma could control glomerular inflammation, modulate vasodilator substances like prostaglandins and NO [6, 7], antagonize glomerulosclerosis of diabetic nephropathy, and improve renal function. In a rat remnant kidney model of renal fibrosis, administration of the PPAR-gamma agonist troglitazone is associated with reduction of proteinuria, improved serum creatinine, and glomerulosclerosis [8]. PPAR-gamma agonists could exert antifibrotic effects on human PTC in high glucose levels by attenuating the production of AP-1, TGF-beta1, and the downstream production of the extracellular matrix protein fibronectin [8, 9]. PPAR-gamma activation also decreases glomerular cell proliferation and suppresses plasminogen activator inhibitor-1 (PAI-1) and TGF-beta expression [10]. Furthermore, it down-regulated TGF-beta1-induced fibronectin expression in mouse glomerular mesangial cells by inhibiting activator protein-1 (AP-1) [11-13]; but the relationship between PPAR-gamma and tubulointerstitial fibrosis is not clear yet. By studying the effects of PPAR-gamma activation on TGF-beta-induced fibrosis and its mechanism, our study demonstrates the potential perspective for the antifibrotic property of PPAR-gamma agonists.
###end p 4
###begin title 5
2. MATERIALS AND METHODS
###end title 5
###begin title 6
Cell culture and treatments
###end title 6
###begin p 7
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 478 482 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 26 29 <span type="species:ncbi:10116">rat</span>
###xml 206 210 <span type="species:ncbi:9913">calf</span>
NRK-49F, the immortalized rat kidney interstitial fibroblast cells were obtained from the Chinese Academy of Sciences. Cells were maintained in DMEM/F-12 medium supplemented with 10% heat-inactivated fetal calf serum (Gibco/BRL) in a humidified atmosphere of 5% CO2/95% air at 37degreesC. The cells were passaged every 4 days and then harvested onto six-well culture plates to 60-70% confluence in the complete medium for 16 hours followed by changing to serum-free medium. TGF-beta1, 15d-PGJ2, troglitazone, and ciglitazone (BIOMOL Research Laboratories, Inc., Plymouth Meeting, Pa) were freshly dissolved in culture media and added to the cultures at the indicated concentrations and for the indicated time periods.
###end p 7
###begin title 8
RNA isolation and Reverse transcriptase-polymerase chain reaction (RT-PCR)
###end title 8
###begin p 9
###xml 173 175 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 190 192 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 354 356 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 499 502 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 552 559 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 1116 1120 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 244 273 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Total RNA from NRK/49F cells was isolated by using a TRIzol extraction kit (Gibco/BRL) according to the manufacturer's directions. First-strand cDNA was synthesized using 2 mug of RNA in 20 muL of reaction buffer by reverse transcription using Moloney murine leukemia virus-derived reverse transcriptase (Promega). Complementary DNA was amplified in 100 muL total volume which contained 50 mmol/L KCl, 20 mmol/L Tris-HCl (pH 8.0), 10 mmol/L deoxynucleoside triphosphate (dNTP), 1.5 mmol/L MgCl2, 1U Taq polymerase, and 10 pmol of specific PCR primers. Table 1 showed the sets of primers used for PCR amplification. Beta-actin was amplified and yielded a 202 bp PCR product as the internal standard. The number of cycles used allowed quantification without saturation. Amplification products were separated by electrophoresis on 1.2% agarose gel, followed by ethidium bromide staining, and then photographed. The amplification bands were quantitated from negative by scanning densitometry. Semiquantitation was done by serial dilution of the input cDNA to measure the mRNA. The proportion of specific gene product to beta-actin product was used for semiquantitive analysis.
###end p 9
###begin title 10
Western blotting
###end title 10
###begin p 11
###xml 170 174 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 378 389 <span type="species:ncbi:3704">horseradish</span>
Extracted protein was loaded on a 10% SDS-PAGE gel and transferred onto nitrocellulose membranes. Then proteins were then blocked and incubated with specific antibodies: beta-actin (Sigma-Aldrich), fibronectin (GIBco), type III collagen (Sigma), Smad2/3, or p-smad2/3 (Santa Cruz Biotechnology, Calif, USA). Membranes were subsequently washed, incubated with specific secondary horseradish peroxidase-conjugated antibodies, and revealed with the enhanced chemiluminescence (ECL) kit (Life Science Products, Boston, Mass, USA). The band intensity was analyzed by scanning densitometry.
###end p 11
###begin title 12
Statistical analysis
###end title 12
###begin p 13
###xml 230 231 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All experiments were repeated at least three times, and the results are presented as mean +/- standard deviation (SD). All data were analyzed by SAS 6.12. ANOVA and t-test were performed for statistical analysis as appropriate. A P value less than .05 was considered to be statistically significant.
###end p 13
###begin title 14
3. RESULTS
###end title 14
###begin p 15
###xml 4 8 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
TGF-beta1-induced CTGF, FN, and Col III mRNA expression in a dose-dependent and time-dependent manner in NRK/49F cells.
###end p 15
###begin p 16
###xml 165 169 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 245 246 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1</xref>
###xml 249 251 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2"> 2</xref>
###xml 373 377 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 481 489 475 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 525 529 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 607 608 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 636 637 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 726 727 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 748 756 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 762 766 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 899 903 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 992 993 977 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The induction of CTGF and ECM expression is a hallmark of renal fibrosis in many types of primary glomerular disease. Therefore, we first examined the effect of TGF-beta1 on CTGF and ECM expression in cultured NRK/49F cells. As shown in Figures 1and 2, NRK/49F cells had basal expression of CTGF, FN, and Col III mRNA. After stimulating with different concentration of TGF-beta1, the expression of CTGF, FN, and Col III mRNA increased significantly in a dose-dependent manner (see Figure 1). After stimulating at 1 ng/mL TGF-beta1 for 1 hour, the expression of CTGF, FN, and Col III mRNA began to increase (P < .05), peaked at 5 ng/mL (P < .01), and decreased at 10 ng/mL but was still greater than that of the control group (P < .01). As shown in Figure 2, TGF-beta1 also induced CTGF, FN, Col III mRNA expression in a time-dependent manner in NRK/49F cells. After stimulating for 6 hours with TGF-beta1 (5 ng/mL), expression of CTGF, FN, and Col III mRNA increased, and peaked at 24 hours (P < .01).
###end p 16
###begin title 17
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 34 39 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Effects of PPAR-gamma agonists on alpha-SMA, CTGF, Col III, and FN mRNA expression
###end title 17
###begin p 18
###xml 17 22 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 128 133 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 148 153 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 238 239 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">3</xref>
###xml 243 245 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4"> 4</xref>
###xml 291 295 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 306 311 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 356 357 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 396 401 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 472 476 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 487 492 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
The induction of alpha-SMA is a hallmark of renal interstitial fibroblast activation. Therefore, we examined the effect of PPAR-gamma activation on alpha-SMA, CTGF, Col III, and FN mRNA expression in cultured NRK/49F. As shown in Figures 3 and 4, 10 muM 15d-PGJ2 dramatically suppressed TGF-beta1-mediated alpha-SMA, CTGF, Col III, and FN mRNA expression (P < .05). Similarly, the synthetic PPAR-gamma agonists troglitazone, and ciglitazone also effectively inhibited TGF-beta1-mediated alpha-SMA, CTGF, Col III, and FN mRNA expression in NRK/49F. Such expression in the troglitazone- and ciglitazone-treated groups was less than that in the 15d-PGJ2 treated group.
###end p 18
###begin title 19
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 38 42 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Effects of PPAR-gamma agonists on TGF-beta-induced FN protein expression
###end title 19
###begin p 20
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 82 86 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 228 232 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 362 366 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 457 462 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 520 521 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Figure 5 demonstrates that 15d-PGJ2, troglitazone, and ciglitazone suppressed TGF-beta1-mediated fibronectin expression in NRK/49F cells. NRK/49F cells expressed a considerable amount of fibronectin at basal conditions, and TGF-beta1 significantly induced FN expression. However, NRK/49F treated with 15d-PGJ2, troglitazone, and ciglitazone counteracted the TGF-beta1-stimulated overproduction of fibronectin. However, the level of fibronectin in five PPAR-gamma agonists treated groups was not significantly different (P > .05).
###end p 20
###begin title 21
###xml 15 19 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Effects of TGF-beta1 on Smads protein expression in NRK/49F
###end title 21
###begin p 22
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 109 113 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Figure 6 shows that NRK/49F had basal expression of phosphorylated smad2/3 protein. After stimulating by TGF-beta1 for 15 minutes, p-Smad2/3 protein expression began to increase, peaked at 1 hour, then began to decrease at 2 hours. There was no difference of total Smad2/3 protein expression.
###end p 22
###begin title 23
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 29 33 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Effects of PPAR-gamma on TGF-beta/Smads protein expression
###end title 23
###begin p 24
###xml 49 54 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 76 80 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 225 233 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 407 408 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
To explore the molecular mechanism by which PPAR-gamma agonists inhibit TGF-beta1-mediated renal fibroblast activation, we studied the effect of 15d-PGJ2, troglitazone, and ciglitazone on Smad signalling pathway. As shown in Figure 7, pretreatment of NRK/49F fibroblasts with 15d-PGJ2, troglitazone, and ciglitazone was able to block Smad phosphorylation. There was no difference in each interfering group (P > .05). Total Smad2/3 protein of each group showed no difference.
###end p 24
###begin title 25
4. DISSCUSSION
###end title 25
###begin p 26
###xml 294 299 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 501 505 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 559 563 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 658 662 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 686 690 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 745 747 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 757 761 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 811 815 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 855 859 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Tubulointerstitial fibrosis (TIF) is the final manifestation of end stage renal disease (ESRD). The major pathological changes of TIF are the proliferation of interstitial fibroblasts, transdifferentiation of fibroblast into myofibroblasts (the major characteristic of which is the increase of alpha-smooth muscular actin expression), and overdepositing of extracellular matrix (ECM) such as fibronectin and collagen type I, type II, and type IV. Of all the cytokines and growth factors involved, TGF-beta1 plays the most important role. The elevation of TGF-beta1 expression is closely correlated with glomerulosclerosis and interstitial fibrosis. Anti-TGF-beta1 antibody and anti-TGF-beta receptor antibody could reduce the production of ECM [14]. As TGF-beta1 has many biological effects, suppression of TGF-beta1 expression/activation or blocking TGF-beta1 at its receptors could result in many biological side effects. Therefore, targeting the downstream mediators of the over-activated signaling pathway is a good way to antagonize the progression of ESRD and thus become the prime focus of current studies.
###end p 26
###begin p 27
###xml 81 85 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 411 415 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 491 495 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 588 592 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 806 810 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1029 1033 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1293 1295 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Connective tissue growth factor (CTGF) is one of the downstream mediators of TGF-beta1-induced fibrosis and it participates in fibroblast proliferation and adhesion and in inducing ECM production. Myofibroblasts transdifferentiated from renal interstitial fibroblasts are major sources of tubulointerstitial ECM. Our study shows that NRK/49F had basal expression of alpha-SMA mRNA until it is stimulated by TGF-beta1, whereupon its expression increased significantly, demonstrating that TGF-beta1 could induce tubulointerstitial fibroblasts to transdifferentiate into myofibroblasts. TGF-beta1 could increase the mRNA expression of the downstream mediator CTGF and major constituents of ECM (collagen type III and fibronectin) in a time-dependent and dose-dependent manner. Our study demonstrates that TGF-beta is one of the major fibrosis-inducing mediators which could induce transdifferentiation of renal fibroblasts and production of ECM. Recently, study by Lin et al. showed that activation of Smad3/4 was essential for TGF-beta1-induced CTGF transcription and that pentoxifylline (PTX), a potent inhibitor of CTGF, could inhibit CTGF expression by interfering with Smad3/4-dependent CTGF transcription through protein kinase A and block the profibrogenic effects of CTGF on renal cells [28].
###end p 27
###begin p 28
###xml 5 10 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 177 178 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 220 225 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 527 528 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 547 548 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 617 619 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 621 623 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 734 736 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 738 740 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 810 815 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 856 861 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 998 1003 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1116 1120 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1143 1148 1120 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1263 1268 1236 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1332 1336 1301 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1500 1502 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1503 1505 1469 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1699 1703 1665 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1706 1708 1669 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 611 615 <span type="species:ncbi:10116">rats</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
###xml 1520 1525 <span type="species:ncbi:9606">human</span>
PPAR-gamma has now become the therapeutic target of research on kidney diseases like diabetic nephropathy, glomerulosclerosis, glomerulonephritis, and hypertensive nephropathy [2]. 15d-PGJ2 is the natural ligand of PPAR-gamma, and thiazolidinediones (TZDs) such as troglitazone, and rosiglitazone are its agonists. It has been proven in animal models (streptozotocin-induced diabetic nephropathy models and 5/6 nephrectomized models) that TZDs could reduce the expression of extraglomerular matrix and ameliorate renal injury [2]. TZDs and 15d-PGJ2 could reduce production of collagen type I and fibronectin in rats [15, 16], and inhibit production of proinflammatory cytokines and chemotactic factors (e.g., NO, COX-2, MCP-1, etc.) [17, 18]. Tubulointerstitial fibroblasts could express basal amounts of PPAR-gamma. Our unpublished study showed that PPAR-gamma could inhibit proliferation of human tubulointerstitial fibroblasts and trigger their apoptosis. However, there are few studies on PPAR-gamma agonists and production of ECM. Our study found that 15d-PGJ2, troglitazone, and rosiglitazone could reduce TGF-beta-induced production of alpha-SMA and ECM (collagen type III and fibronectin) and inhibit expression of CTGF mRNA. These results show that PPAR-gamma agonists have an antifibrotic effect through inhibition of TGF-beta-induced renal fibroblast transdifferentiation and ECM production. Such results are similar to those results of studies on glomerulosclerosis and arteriosclerosis [19-21]. Exposure of human cortical fibroblasts to pioglitazone causes an antiproliferative effect and reduces ECM production through mechanisms that include reducing TIMP activity independent of TGF-beta1 [22].
###end p 28
###begin p 29
###xml 15 20 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 114 119 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 252 256 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 327 332 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 359 364 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 432 434 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 450 455 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 469 473 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 525 530 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 580 585 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 685 689 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 788 790 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1061 1063 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1150 1155 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 260 264 <span type="species:ncbi:10116">rats</span>
Different PPAR-gamma ligands or agonists may have different mechanisms in different cells and there are also PPAR-gamma independent pathways involved. Baoling found that pioglitazone, and 15d-PGJ2 could inhibit expression of fibronectin induced by TGF-beta in rats and the effects of pioglitazone are due to activation of PPAR-gamma. However, there were PPAR-gamma-independent pathways involved in the mechanism of 15d-PGJ2 action [16]. Whether PPAR-gamma inhibits TGF-beta1-induced fibrosis by activating intracellular PPAR-gamma-receptors requires further study. Different PPAR-gamma agonists may even have opposite effects. Sawano's study shows that 15d-PGJ2 could downregulate IL-1beta-induced COX-2 expression and troglitazone/rosiglitazone could not reduce the expression of COX-2 [17]. Panzer found that in experimental glomerulonephritis induced by ATS (antithymus antibody), troglitazone, and ciglitazone could upregulate MCP-1 expression and increase monocyte/macrophage infiltration and adhesion, however, 15d-PGJ2 has no effect on MCP-1 expression [23]. Our study shows that troglitazone, and ciglitazone have a more inhibitory effect on alpha-SMA expression than 15d-PGJ2. Comparing the intervention of different reagents, the expression of CTGF, collagen type III, and fibronectin shows no difference. Such results suggest that these reagents have similar effects on fibrosis.
###end p 29
###begin p 30
###xml 76 80 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 135 139 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 211 213 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 215 217 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 256 260 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 336 338 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 373 377 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 549 551 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 579 583 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 669 673 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 790 794 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 916 921 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 972 976 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1225 1230 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1398 1402 1366 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1441 1443 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1559 1563 1524 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Phosphorylated Smad2/Smad3 (p-Smad2/3) is the main signaling pathway of TGF-beta1 and it participates in the biological effects of TGF-beta which include cell proliferation, inflammation reaction, and fibrosis [24, 25]. They are essential mediators of TGF-beta-induced endothelial cell transdifferentiation and ECM and CTGF expression [26]. Studies have shown that the TGF-beta/Smads signaling pathway participates in many pathophysiological processes related to kidney diseases like diabetic nephropathy, glomerulonephritis and glomerulosclerosis [27]. Our study shows that TGF-beta1 induces Smad2/3 phosphorylation in a time-dependent manner, which suggests that TGF-beta could induce Smad2/3 phosphorylation in renal fibroblasts. 15d-PGJ2, troglitazone, and ciglitazone could reduce TGF-beta-induced p-Smad2/3 protein expression while the total amount of Smad2/3 protein did not change. Such results suggest PPAR-gamma agonists could inhibit the fibrotic effect of TGF-beta by interfering in the phosphorylation of Smad2/3. Moreover, all three reagents show no significant difference in inhibiting phosphorylation of Smad2/3. Our study suggests that Smad 2/3 signaling pathway is essential in antifibrotic effects of PPAR-gamma agonists. While in the study by Yang et al., Smad 2/3 phosphorylation was not inhibited by hepatocyte growth factor (HGF), which acts as a potent inhibitor of the TGF-beta1-mediated myofibroblastic activation [29] Therefore, further study is required to investigate role of Smad signaling pathway in different inhibitors of TGF-beta1-mediated myofibroblastic activation.
###end p 30
###begin p 31
###xml 20 25 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 47 51 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 88 92 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 189 194 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
In conclusion, PPAR-gamma could antagonize TGF-beta-induced fibrosis by interfering TGF-beta/Smad signaling pathway. Such results suggest a perspective for the antifibrotic effects of PPAR-gamma and such effects may become the therapeutic target of ESRD.
###end p 31
###begin title 32
ACKNOWLEDGMENTS
###end title 32
###begin p 33
This work was supported by grants from the National Nature Science Foundation of China (30270613 and 30771000), Leading Academic Discipline Project of Shanghai Health Bureau (05 001 and 2003ZD002), and Shanghai Leading Academic Discipline Project (T0201).
###end p 33
###begin article-title 34
Role of fibroblast activation in inducing interstitial fibrosis
###end article-title 34
###begin article-title 35
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease
###end article-title 35
###begin article-title 36
###xml 78 85 <span type="species:ncbi:9986">rabbits</span>
###xml 90 96 <span type="species:ncbi:9606">humans</span>
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
###end article-title 36
###begin article-title 37
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney
###end article-title 37
###begin article-title 38
###xml 97 100 <span type="species:ncbi:10116">rat</span>
Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney
###end article-title 38
###begin article-title 39
###xml 112 116 <span type="species:ncbi:10116">rats</span>
Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats
###end article-title 39
###begin article-title 40
###xml 105 110 <span type="species:ncbi:9606">human</span>
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro
###end article-title 40
###begin article-title 41
###xml 116 120 <span type="species:ncbi:10116">rats</span>
Peroxisome proliferator-activated receptor- agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
###end article-title 41
###begin article-title 42
###xml 121 125 <span type="species:ncbi:10116">rats</span>
Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats
###end article-title 42
###begin article-title 43
PPAR- agonists exert antifibrotic effects in renal tubular cells exposed to high glucose
###end article-title 43
###begin article-title 44
Peroxisome proliferator-activated receptor- ligands inhibit TGF-1-induced fibronectin expression in glomerular mesangial cells
###end article-title 44
###begin article-title 45
###xml 93 98 <span type="species:ncbi:9606">human</span>
Pioglitazone attenuates TGF-1-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)
###end article-title 45
###begin article-title 46
###xml 120 127 <span type="species:ncbi:9986">rabbits</span>
Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits
###end article-title 46
###begin article-title 47
Effects of anti-TGF- type II receptor antibody on experimental glomerulonephritis
###end article-title 47
###begin article-title 48
Upregulation of type I collagen by TGF- in mesangial cells is blocked by PPAR- activation
###end article-title 48
###begin article-title 49
Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPAR gamma-independent signaling pathways
###end article-title 49
###begin article-title 50
15-deoxy--prostaglandin  inhibits IL-1-induced cyclooxygenase-2 expression in mesangial cells
###end article-title 50
###begin article-title 51
Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses
###end article-title 51
###begin article-title 52
Peroxisome proliferator-activated receptors ligands, oxidative stress, and cardiac fibroblast extracellular matrix turnover
###end article-title 52
###begin article-title 53
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Peroxisome proliferator-activated receptor 1 (PPAR1) expresses in rat mesangial cells and PPAR agonists modulate its differentiation
###end article-title 53
###begin article-title 54
###xml 61 66 <span type="species:ncbi:9606">human</span>
Activation of peroxisome proliferator-activated receptor  in human endothelial cells increases plasminogen activator inhibitor type-1 expression
###end article-title 54
###begin article-title 55
###xml 67 72 <span type="species:ncbi:9606">human</span>
Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts
###end article-title 55
###begin article-title 56
Effects of different PPAR-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis
###end article-title 56
###begin article-title 57
Mechanisms of TGF- signaling from cell membrane to the nucleus
###end article-title 57
###begin article-title 58
TGF- signaling and the fibrotic response
###end article-title 58
###begin article-title 59
Smad3 as a mediator of the fibrotic response
###end article-title 59
###begin article-title 60
Transforming growth factor- and Smad signalling in kidney diseases
###end article-title 60
###begin article-title 61
Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor
###end article-title 61
###begin article-title 62
Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction
###end article-title 62
###begin p 63
###xml 4 8 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 81 82 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 106 107 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
TGF-beta1-induced CTGF, FN, Col III mRNA expression in a DOSE-dependent manner, *P < .05 versus control; #P < .01 versus control (n=3 for each group).
###end p 63
###begin p 64
###xml 4 8 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 81 82 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 120 124 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 210 211 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 235 236 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 333 334 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 508 512 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 619 623 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 283 289 <span type="species:ncbi:9913">bovine</span>
TGF-beta1-induced CTGF, FN, Col III mRNA expression in a time-dependent manner, *P < .05 versus control; effects of TGF-beta1 on CTGF, FN, Col III mRNA expression in NRK/49F. NRK/49Fs were cultured in the 25 cm2 culture flash by 1 x 106 which contains DMEM/F12 medium with 10% fetal bovine serum, and cultured in the 37degreesC, 5%CO2 incubator. When the cells were 80-90% confluent, continued to culture in the DMEM/F12 medium without serum for 24 hours to synchronize cell growth. Different dosages of TGF-beta1 (0, 1, 2, 5, 10 ng/mL) were added to the medium and the cells were cultured for another 24 hours, or TGF-beta1 was added (5 ng/mL) to the medium and cultured for different times (0, 6, 12 and 24 hours). Both control and experimental groups repeated for 3 times.
###end p 64
###begin p 65
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 38 42 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 52 57 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 234 238 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 283 287 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 448 452 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 488 492 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 532 536 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 575 579 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 589 590 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 614 615 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 641 645 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 654 655 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effects of PPAR-gamma agonists on TGF-beta1-induced alpha-SMA, FN, Col III mRNA expression. Cells were cultured as described above and pretreated by 10 uM 15d-PGJ2, troglitazone, and ciglitazone for 2 hours and then added 5 ng/mL TGF-beta1. Set a blank control group and 5 ng/mL TGF-beta1 stimulating group, cultured for 24 hours and then harvested the cells. Both control and experimental groups repeated for 3 times. (1) control, (2) 5 ng/mL TGF-beta1 group, (3) 15d-PGJ2 + 5 ng/mL TGF-beta1 group, (4) troglitazone + 5 ng/mL TGF-beta1 group, (5) ciglitazone + 5 ng/mL TGF-beta1 group, *P < .05 versus control, #P < .05 versus 5 ng/mL TGF-beta1 group, P < .05 versus 15d-PGJ2 group.
###end p 65
###begin p 66
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 38 42 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 74 75 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 126 130 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 161 165 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 205 209 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 252 256 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 265 266 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 290 291 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 317 321 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 330 331 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effects of PPAR-gamma agonists on TGF-beta1-induced CTGF mRNA expression (n = 3 for each group), (1) control, (2) 5 ng/mL TGF-beta1 group, (3) 15d-PGJ  ng/mlTGF-beta1 group, (4) troglitazone + 5 ng/mL TGF-beta1 group, and (5) ciglitazone + 5 ng/mL TGF-beta1 group, P < .05 versus control, #P < .05 versus 5 ng/mL TGF-beta1 group, P < .05 versus 15d-PGJ2 group.
###end p 66
###begin p 67
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 29 33 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 161 165 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 191 195 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 214 218 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 260 264 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 310 314 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 359 363 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Effects of PPAR-gamma on TGF-beta1-induced FN protein expression. Cells were cultured in the methods described above. Set groups: (1) control group (without TGF-beta1), (2) added 2 ng/mL TGF-beta1; (3) 5 ng/mL TGF-beta1 group; (4) 10 uM 15d-PGJ2 + 5 ng/mL TGF-beta1 group; (5) 10 uM Troglitazone + 5 ng/mL TGF-beta1 group; (6) 10 uM ciglitazone + 5 ng/mL TGF-beta1 group (all the three reagents were pretreated for 2 hours). All the cells in each group were cultured for 24 hours and then harvested cells, extracted total protein (results of one of the three repeated experiments).
###end p 67
###begin p 68
###xml 15 19 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Effects of TGF-beta1 on Smad2/3, p-smad2/3 protein expression in NRK/49F (results of one of three repeated experiments).
###end p 68
###begin p 69
###xml 16 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 29 33 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 149 153 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 178 182 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 218 222 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 262 266 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 305 309 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Effects of PPAR-gamma on TGF-beta1-induced Smads protein expression (results of one of the three repeated experiments): (1) control, (2) 2 ng/mL TGF-beta1 group, (3) 5 ng/mL TGF-beta1 group, (4) 15d-PGJ2 + 5 ng/mL TGF-beta1 group, (5) troglitazone + 5 ng/mL TGF-beta1 group, (6) ciglitazone + 5 ng/mL TGF-beta1 group,
###end p 69
###begin p 70
PCR primer sequence and conditions.
###end p 70

